Xianlong Chen

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0002-3677-4281

发表论文 35 篇 · 总被引 297 次 · h-index 8

代表论文

• Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma (2022 · The Journal of Pathology Clinical Research · 被引 57)
• Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma (2023 · Cell Death and Differentiation · 被引 55)
• PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules (2022 · The Journal of Pathology Clinical Research · 被引 40)
• Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma (2022 · Frontiers in Immunology · 被引 20)
• High Mast Cell Density Predicts a Favorable Prognosis in Patients with Pancreatic Neuroendocrine Neoplasms (2021 · Neuroendocrinology · 被引 15)
• The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma (2023 · Theranostics · 被引 12)